Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... - MarketWatch (press release)

Third Peer-Reviewed Study Proves Botanical Formula Fights Prostate Cancer ... MarketWatch (press release) 8, 2012 /PRNewswire via COMTEX/ -- Scientists at Indiana University, Methodist Research Institute, study a botanical formula that kills aggressive prostate cancer tumors. Their findings, based on experiments in mice using a human prostate cancer tumor ... and more »

Benefit of Bone Drug in Prostate Cancer in Doubt - MedPage Today

USA TODAY

Benefit of Bone Drug in Prostate Cancer in Doubt MedPage Today "Though the study met the prespecified primary endpoint, with a statistically significant prolongation in [bone metastases free survival], it is unclear whether an improvement [of] 4.2 months alone in patients with [castrate-resistant prostate cancer] ... FDA questions Amgen drug for prostate cancerUSA TODAY Can Amgen Convince Docs to Recommend Approval?DailyFinance FDA Questions Benefit of Amgen Bone Drug in Certain CasesWall Street Journal (blog) GlobalPost all 222 news articles »